In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
The Hepatitis C Transplant Collaborative
-
Baylor Scott & White Health Research Institute, Dallas, Texas, United States, 75246
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
Baylor Research Institute,
Shelley A Hall, MD FACC, PRINCIPAL_INVESTIGATOR, BSWRI
2023-12